Romero-Ibarguengoitia Maria Elena, Garza-Silva Arnulfo, Rivera-Cavazos Andrea, Morales-Rodriguez Devany Paola, González-Peña Omar Israel, Barco-Flores Irene Antonieta, Manilla-Muñoz Edgar, Villarreal-Leal Enrique, González-Cantú Arnulfo
Escuela de Medicina, Vicerrectoría de Ciencias de la Salud, Universidad de Monterrey, 66238 San Pedro Garza García, Nuevo León, Mexico.
Research Department, Hospital Clínica Nova de Monterrey, 66450 San Nicolás de los Garza, Nuevo León, Mexico.
J Endocr Soc. 2024 Jan 2;8(2):bvad175. doi: 10.1210/jendso/bvad175. eCollection 2024 Jan 5.
Hypothyroidism is conventionally treated with replacement therapy through levothyroxine (LT4). Despite the improvement in symptoms, cold intolerance persists in some patients. The present study aims to determine whether there is a difference in temperature perception and skin temperature between patients with primary controlled hypothyroidism (PCH) and a group of healthy controls matched for body mass index and age. Secondarily we aimed to determine difference in quality of life.
Skin temperature measurements were performed in both groups, both in the central and peripheral regions of the body. In addition, subjects were asked about their perception of temperature in a temperature-controlled room; anthropometric measurements were taken, their quality of life was assessed using the ThyPRO-39, and a thyroid hormone profile was performed.
Eleven patients in the PCH group and 30 patients in the control group were studied. It was found that the group with PCH presented a significantly lower palmar temperature than the control group [mean (SD) of 32.05 (1.79) vs 33.10 (1.30) oC, = .046]. A mediation model showed a direct effect. Temperature perception was equal between groups. The median (interquartile range) of ThyPRO was 8 (5.2) points in the control group vs 21.8 (13.5) in the group of controlled hypothyroidism, < .001.
These results suggest that, despite LT4 treatment, patients continue to present abnormalities in thermogenesis-related thermogenesis, and this may be due to a lack of hormonal adaptation to environmental changes and physiological demands, leading to lower body temperatures and increased sensitivity to cold.
传统上,甲状腺功能减退症通过左甲状腺素(LT4)替代疗法进行治疗。尽管症状有所改善,但一些患者仍存在不耐寒的情况。本研究旨在确定原发性控制型甲状腺功能减退症(PCH)患者与一组体重指数和年龄相匹配的健康对照组在温度感知和皮肤温度方面是否存在差异。其次,我们旨在确定生活质量的差异。
对两组患者进行了皮肤温度测量,测量部位包括身体的中央和外周区域。此外,在温度可控的房间里询问受试者对温度的感知;进行人体测量,使用ThyPRO-39评估他们的生活质量,并进行甲状腺激素谱分析。
对PCH组的11名患者和对照组的30名患者进行了研究。发现PCH组的手掌温度明显低于对照组[平均(标准差)为32.05(1.79)℃,对照组为33.10(1.30)℃,P = 0.046]。中介模型显示存在直接效应。两组之间的温度感知相同。对照组ThyPRO的中位数(四分位间距)为8(5.2)分,而控制型甲状腺功能减退症组为21.8(13.5)分,P < 0.001。
这些结果表明,尽管进行了LT4治疗,但患者在与产热相关的体温调节方面仍存在异常,这可能是由于激素缺乏对环境变化和生理需求的适应性,导致体温降低和对寒冷的敏感性增加。